Bend Research Inc. has received certification of compliance with EU GMP regulations. The certification was granted by Sweden’s Medical Products Agency (MPA) and covers the manufacture of clinical pharmaceutical supplies and testing of those supplies at the company’s GMP facilities.
 
“The strategic addition of this certification—combined with new capabilities such as high-potency spray-drying and future commercial spray-drying—strengthens Bend Research’s position as a preferred provider for oral solubilized, modified-release, inhalation, and many other dosage forms,” said Rod Ray, Bend Research chief executive officer. “We knew the EU’s quality standards were stringent, but we were confident that our operations met those high standards and were eager to demonstrate that to our customers.”